The liver and kidney in critically ill patients

Blood Purification

Volumn 28, Issue 2, 2009, Pages 124-134

  Slack, Andrew J ^a   Wendon, Julia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acute kidney injury; Cirrhotic cardiomyopathy; Hepatorenal syndrome; Renal blood flow

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; ANTIBIOTIC AGENT; DIURETIC AGENT; HYPERTENSIVE FACTOR; MIDODRINE; NORADRENALIN; NORFLOXACIN; OCTREOTIDE; PLACEBO; STEROID; TERLIPRESSIN; TRACE ELEMENT; VASOPRESSIN DERIVATIVE; VITAMIN;

ACUTE KIDNEY FAILURE; ADRENERGIC SYSTEM; ALBUMIN DIALYSIS; ANTIBIOTIC PROPHYLAXIS; ASCITES; BACTERIAL PERITONITIS; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CONVALESCENCE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG INFUSION; DRUG WITHDRAWAL; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEMODIALYSIS; HEMODYNAMICS; HEPATORENAL SYNDROME; HUMAN; INTENSIVE CARE; KIDNEY DYSFUNCTION; KIDNEY INJURY; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RECOMMENDED DRUG DOSE; RENAL REPLACEMENT THERAPY; RESPIRATORY CARE; RESPIRATORY TRACT DISEASE; RESUSCITATION; REVIEW; SPLANCHNIC BLOOD FLOW; SURVIVAL TIME; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

HEPATORENAL SYNDROME; HUMANS; KIDNEY; LIVER;

EID: 67649876080     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227281     Document Type: Review

References (41)

1. Hoste EAJ, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA: RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Critical Care 2006;10:R73 (Pubitemid 47086852)
2. Ng CKF, Chan MHM, Tai MHL, Lam CWK: Hepatorenal syndrome. Clin Biochem Rev 2007;28:11-17.
3. Betrosian AP, Douzinas EE, Agarwal B: Acute renal dysfunction in liver diseases. World J Gastroenterol 2007;13:5552-5559. (Pubitemid 350031474)
4. Hegarty J, Middleton RJ, Krebs M, et al: Severe acute renal failure in adults: place of care, incidence and outcomes. QJM 2005;98:661-666. (Pubitemid 41236095)
5. Nash K, Hafeez A, Hou S: Hospital acquired renal insufficiency. Am J Kidney Dis 2002;39:930-936.
6. Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM: The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis 2005;46:1038-1048. (Pubitemid 41690229)
7. Gines A, Escorsell A, Gines P, et al: Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis and ascites. Gastroenterology 1993;105:229-236. (Pubitemid 23234041)
8. Gines P, Martin PY, Niederberger M: Prognostic significance of renal dysfunction in cirrhosis. Kidney Int 1997;51(suppl):S77-S82. (Pubitemid 27435868)
9. Angeli P, Merkel C: Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol 2008;48:93-103.
10. Rivolta R, Maggi A, Cazzaniga M, et al: Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites. Hepatology 1998;28:1235-1240. (Pubitemid 28493832)
11. Dagher L, Moore K: The hepatorenal syndrome. Gut 2001;49:729-737.
12. Wiest R, Groszmann RJ: The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002;35:478-491. (Pubitemid 34110432)
13. Soper CPR, Latif AB, Bendino MR: Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet 1996;347:1842-1843.
14. Islas-Carbajal MC, Covarrubias A, Grijalva G, Alvarez-Rodríguez A, Armendáriz-Borunda J, Rincón-Sánchez AR: Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver Int 2005;25:131-140. (Pubitemid 40298255)
15. 2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983;13:271-278.
16. Bichet DG, Van Putten VJ, Schrier RW: Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982;307:1552-1557.
17. Jalan R, Forest EH, Redhead DN, Dillon JF, Hayes PC: Reduction in renal blood flow following acute increase in portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 1997;40:664-670.
18. Ming Z, Smyth DD, Wayne Lautt W: Decreases in portal flow trigger a hepatorenal reflex to inhibit renal sodium and water excretion in rats: role of adenosine. Hepatology 2002;35:167-175. (Pubitemid 34032557)
19. Nagarakanti R, Whellan D, Rubin S, Mather PJ: Reversible cardiomyopathies. Cardiol Rev 2007;15:178-183.
20. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L: The cardiac response to exercise in cirrhosis. Gut 2001;49:268-275.
21. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, De Castro S, Merli M: Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000;95:3200-3205. (Pubitemid 30826297)
22. Liu H, Song D, Lee SS: Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002;26:842-847.
23. Epstein M: Hepatorenal syndrome; in Brady HR, Wilcox CS (eds): Therapy in Nephrology and Hypertension - A Companion to Brenner and Rector's the Kidney, chapt 8. Philadelphia, Saunders, 1999, pp 45-50.
24. Mehta RL, Kellum JA, Shah SV, Molitori BA, Ronco C, Warnock DG, Levin A, and the Acute Kidney Injury Network (AKJN): Report of an initiative to improve outcomes in acute kidney injury. Critical Care 2007;11:R31. (Pubitemid 46604959)
25. Bagshaw SM, George C, Bellomo R, et al: A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23:1203-1210. (Pubitemid 351767483)
26. Jeng CC, Tsai MH, Tian YC, Lin CY, Yang C, Liu NJ, Lien JM, Chen YC, Fang JT, Chen PC, Yang CW: RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 2007;33:1921-1930. (Pubitemid 47632256)
27. Kupin W: Renal Disease Complicating Advanced Liver Disease. Alexandria/VA, American Association for the Study of Liver Disease, pp 221-226.
28. Mandal AK, Lansing M, Fahmy A: Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study. Am J Kidney Dis 1982;2:363-374. (Pubitemid 13142501)
29. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A: Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of three preventive strategies. Circulation 2007;115;1211-1217. (Pubitemid 46594764)
30. Hogan SE, L'Allier P, Chetcuti S, Grossman PM, Nallamothu BK, Duvernoy C, Bates E, Moscucci M, Gurm HS: Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J 2008;156:414-421.
31. Sort P, Navasa M, Arroyo V, et al: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-409. (Pubitemid 29362513)
32. Fernández J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V, Such J, Ginès P, Arroyo V: Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007;133:818-824. (Pubitemid 47374144)
33. Tiani C, Abraldes JG, Bosch J: Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding. Dig Liver Dis 2008;40:318-327.
34. Dellenger RP, Levy M, Carlet JM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care 2008;36:296-327.
35. Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, Thomas M, Patch D, Burroughs AK: Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007;13:523-529. (Pubitemid 46605854)
36. Pawarode A, Fine DM, Thuluvath PJ: Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003;9:741-747. (Pubitemid 36874464)
37. Solanki P, Chawala A, Garg R, Gupta R, Jain M, Sarin SK: Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 2003;18:152-156. (Pubitemid 36349860)
38. Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Gulberg V, Sigal S, Teuber P; Terlipressin Study Group: A randomized prospective double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008;134:1360-1368. (Pubitemid 351615358)
39. Wong F, Pantea L, Sniderman K: Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004;40:55-64. (Pubitemid 38868923)
40. Bresing KA, Textor J, Perez J, et al: Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000;47:288-295. (Pubitemid 30489776)
41. Mitzner SR, Stange J, Klammt S, et al: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results on a prospective, randomized controlled clinical trial. Liver Transpl 2000;6:277-286. (Pubitemid 30317221)